Product description

Miltefosine is a pharmaceutical substance for the treatment of parasite-induced leishmaniasis. It is used in human and veterinary medicines and is taken orally in the form of tablets.

Comprehensive documentation for drug registration of Miltefosine can be provided by Biesterfeld as referred.

CAS-No. Regulatory Monograph
58066-85-6 ASMF IH


Miltefosine (Antileishmanial)

Country availability

Available worldwide

Hans-Günter Kainz

Contact person

Hans-Günter Kainz

General Manager

email   phone